Biotech firm Check Cap rises on smaller-than-expected Q3 loss

Mbody Ai

30/11/2022 15:41

** U.S.-listed shares of Israel-based biotech firm Check Cap
Ltd  CHEK.O  rise 18.7% to $3.5
    ** Co reports a Q3 diluted loss of 4 cents per share,
beating analysts' expectations for a wider quarterly loss of 90
cents - Refinitiv 
    ** CHEK believes it has sufficient capital to fund its
ongoing operations and plans into Q2 of 2024 
    ** Including session's gain, stock is down ~74% YTD
 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))